Article
Real-world diagnostic testing patterns for assessment of ring sideroblasts and SF3B1 mutations in patients with newly diagnosed lower-risk myelodysplastic syndromes.
International journal of laboratory hematology - 1 Jun 2021
Patel Jay L, Abedi Mehrdad, Cogle Christopher R, Erba Harry P, Foucar Kathryn, Garcia-Manero Guillermo, Grinblatt David L, Komrokji Rami S, Kurtin Sandra E, Maciejewski Jaroslaw P, Pollyea Daniel A, Revicki Dennis A, Roboz Gail J, Savona Michael R, Scott Bart L, Sekeres Mikkael A, Steensma David P, Thompson Michael A, Dawn Flick Elizabeth, Kiselev Pavel, Louis Chrystal U, Nifenecker Melissa, Swern Arlene S, George Tracy I
Abstract excerpt
INTRODUCTION: The presence of ring sideroblasts (RS) and mutation of the SF3B1 gene are diagnostic of lower-risk (LR) myelodysplastic syndromes (MDS) and are correlated with favorable outcomes. However, information on testing and reporting in community-based clinical settings is scarce. This study from the Connect® MDS/AML Disease Registry aimed to compare the frequency of RS and SF3B1 reporting for patients with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.